Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens. Br J Cancer 1993; 67: 801 - 5. (M1: 1088)A'Hern RP, Smith IE, Ebbs SR: Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens. Br...
year overall survival rate ranging between 13 to 24% after simple operation, and local recurrence rate in 5 years is about 48%4. With the introduction of routine treatment methods such as radiotherapy and chemotherapy accompanying surgery for these patients, the 5 year survival rate now pegs...
We meas- ured the survival of seventy-eight consecutively treated patients using univariate survival statistics. We report on the survival of these patients after stratifying for the known prognostic variables. Currently, forty-five of the patients have died. Demographically, the patients' ages ranged...
Individualized treatment of osteosarcoma may improve chemotherapy efficacy and the survival rate of osteosarcoma patients. High-throughput genotyping allows mapping of osteosarcoma mutations, and novel gene mutations offered new candidates for diagnosis and therapeutic targeting....
Primary endpoint was Complete Response to induction UFTVP and secondary endpoints were Disease Free Status Rate after locoregional treatment and long-term Overall Survival. Between 1994 and 1997, 32 pts were included. Results. Complete Response to Induction UFTVP was 59% (95% CI: 48%-70%). ...
et al. Integrated single-cell and bulk RNA sequencing analysis identifies a neoadjuvant chemotherapy-related gene signature for predicting survival and therapy in breast cancer. BMC Med Genomics 16, 300 (2023). https://doi.org/10.1186/s12920-023-01727-0 Download citation Received12 April 2023 ...
efficiency, but can improve TTP and 1-year survival rate for patients with advanced NSCLC who receive chemotherapy. 【Key words】 Invigorating spleen and kidney therapy; Non-small-cell lung cancer; Chemotherapy; Time to progression; 1-year survival rate;Integrated traditional Chinese and western me...
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet, 365 (2005), pp. 1687-1717 Google Scholar 2 Early Breast Cancer Trialists' Collaborative Group Introduction and methods Treatment of early breast cance...
Overall survival AJCC: American Joint Committee on Cancer VOLI: Vascular or lymphatic invasion NI: Nervous invasion References Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 canc...
primary treatment or as an adjuvant to the drugs mentioned above. Radiation therapy also causes a large amount of collateral damage to healthy cells frequently limiting its usage. In spite of improvements in cancer treatment, the overall survival rate of cancer patients has not drastically improved....